BioCryst Pharmaceuticals, Inc. Share Price
Stocks
BCRX
US09058V1035
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
Pre-market 00:00:10 | |||
| 10.72 USD | -3.51% |
|
10.69 | -0.28% |
| Market Cap | 2.82B 2.47B 2.28B 2.11B 4B 269B 4.07B 27.25B 10.68B 133B 10.6B 10.37B 458B | P/E 2026 * |
-4.25x | P/E 2027 * | 20.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.82B 2.47B 2.28B 2.11B 4B 269B 4.07B 27.25B 10.68B 133B 10.6B 10.37B 458B | EV / Sales 2026 * |
4.21x | EV / Sales 2027 * | 3.88x |
| Free-Float |
94.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BioCryst Pharmaceuticals, Inc.
| 1 day | -3.51% | ||
| 1 week | +11.09% | ||
| Current month | +7.20% | ||
| 1 month | +27.16% | ||
| 3 months | +9.61% | ||
| 6 months | +40.68% | ||
| Current year | +37.44% |
| 1 week | 9.71 |  | 11.22 |
| 1 month | 8.1 | | 11.22 |
| Current year | 6.23 | | 11.22 |
| 1 year | 6 | | 11.22 |
| 3 years | 4.03 | | 11.31 |
| 5 years | 4.03 | | 19.99 |
| 10 years | 1.38 | | 19.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charles Gayer
CEO | Chief Executive Officer | 55 | 31/12/2025 |
Babar Ghias
DFI | Director of Finance/CFO | 47 | 06/07/2025 |
Sandeep Menon
CTO | Chief Tech/Sci/R&D Officer | 51 | 05/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Stonehouse
BRD | Director/Board Member | 65 | 31/12/2006 |
Theresa Heggie
BRD | Director/Board Member | 64 | 02/12/2018 |
Charles Gayer
BRD | Director/Board Member | 55 | 31/12/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Free | Director | 48,834 | 0.0192% | ||
| 06-10 | Free | Director | 48,834 | 0.0192% | ||
| 06-10 | Free | Director | 48,834 | 0.0192% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.51% | +11.09% | +21.96% | +53.58% | 2.82B | |
| -0.38% | +0.40% | +71.69% | +128.83% | 56.71B | |
| +4.91% | -3.30% | +71.97% | +92.14% | 51.3B | |
| +1.48% | +10.52% | +23.01% | +495.47% | 25.26B | |
| -0.59% | -1.00% | -16.73% | -12.99% | 23.65B | |
| +3.93% | +7.11% | +44.20% | -1.96% | 18.69B | |
| +2.01% | +7.22% | +41.55% | -24.93% | 17.71B | |
| -6.84% | +4.81% | +201.88% | +348.11% | 17.7B | |
| -0.92% | +8.90% | +38.48% | - | 14.26B | |
| +1.76% | +5.82% | +31.23% | +195.70% | 14.1B | |
| Average | +0.19% | +4.62% | +52.92% | +141.55% | 24.22B | |
| Weighted average by Cap. | +1.01% | +2.31% | +58.34% | +144.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 671M 587M 541M 500M 951M 64B 967M 6.48B 2.54B 31.49B 2.52B 2.46B 109B | 727M 636M 587M 542M 1.03B 69.36B 1.05B 7.02B 2.75B 34.13B 2.73B 2.67B 118B |
| Net income | -645M -564M -520M -481M -913M -61.47B -929M -6.22B -2.44B -30.25B -2.42B -2.37B -105B | 144M 126M 116M 107M 203M 13.69B 207M 1.39B 543M 6.74B 539M 527M 23.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | US$10.72 | -3.51% | 3,868,962 |
| 08/07/26 | US$11.11 | +1.09% | 7,429,410 |
| 07/07/26 | US$10.99 | +8.06% | 10,280,196 |
| 06/07/26 | US$10.17 | +3.35% | 4,380,034 |
| 02/07/26 | US$9.840 | +1.97% | 4,860,048 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BCRX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
